At a glance
ClinicalIndex Comparison RecordN/ACompleted· 287 enrolled
Drug / intervention
VisAbility™ Micro Insertdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multicenter Clinical Trial of the VisAbility™ Micro Insert System for the Improvement of Near Visual Acuity in Presbyopic Subjects - Long Term Follow-up
In Brief
A clinical study evaluating VisAbility™ Micro Insert for Presbyopia. Completed, enrolled 287 participants across 13 sites.
Detailed Summary
The objective of this study is to obtain an additional 36 months of safety and effectiveness data from all subjects who were implanted with the VisAbility™ Micro Insert in the VIS-2014 clinical trial.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartDec 2018
First PostedJan 2019
Primary CompletionOct 2021
Study CompletionOct 2021
TodayJul 2026
First PostedJan 22, 2019
Enrollment StartDec 3, 2018
Primary CompletionOct 1, 2021
Study CompletionOct 29, 2021
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 7.4 years ago
Interventions
VisAbility™ Micro Insertdevice
No (new) intervention will be administered during the course of this long term follow-up study. Subjects that previously participated in the VIS-2014 clinical trial that had VisAbility™ Micro Inserts surgically implanted in the eye(s) will be followed prospectively.